Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Operating Expenses | 8,533 | 5,257 | 0 | 0 |
| Operating Income | -8,533 | -5,257 | N/A | N/A |
| Other Income | 16 | 21 | 0 | 0 |
| Pre-tax Income | -8,517 | -5,236 | 0 | 0 |
| Net Income Continuous | -8,517 | -5,236 | N/A | N/A |
| Net Income | $-8,517 | $-5,236 | $N/A | $N/A |
| EPS Basic Total Ops | -6.15 | -6.45 | N/A | N/A |
| EPS Basic Continuous Ops | -4.95 | -4.84 | N/A | N/A |
| EPS Diluted Total Ops | -6.15 | -6.45 | N/A | N/A |
| EPS Diluted Continuous Ops | -4.95 | -4.84 | N/A | N/A |
| EBITDA(a) | $-8,521 | $-5,246 | $N/A | $N/A |